Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1β-driven venous thrombosis.

Yadav V, Chi L, Zhao R, Tourdot BE, Yalavarthi S, Jacobs BN, Banka A, Liao H, Koonse S, Anyanwu AC, Visovatti SH, Holinstat MA, Kahlenberg JM, Knight JS, Pinsky DJ, Kanthi Y.

J Clin Invest. 2019 Apr 16;130. pii: 124804. doi: 10.1172/JCI124804.

2.

Barriers to physical activity in patients with pulmonary hypertension.

Cascino TM, McLaughlin VV, Richardson CR, Behbahani-Nejad N, Moles VM, Visovatti SH, Jackson EA.

Pulm Circ. 2019 Apr-Jun;9(2):2045894019847895. doi: 10.1177/2045894019847895.

3.

Physical activity and quality of life in patients with pulmonary hypertension.

Cascino TM, McLaughlin VV, Richardson CR, Behbahani-Nejad N, Moles VM, Visovatti SH, Jackson EA.

Eur Respir J. 2019 Jun 20;53(6). pii: 1900028. doi: 10.1183/13993003.00028-2019. Print 2019 Jun. No abstract available.

PMID:
30880287
4.

Nanoparticle-macrophage interactions: A balance between clearance and cell-specific targeting.

Rattan R, Bhattacharjee S, Zong H, Swain C, Siddiqui MA, Visovatti SH, Kanthi Y, Desai S, Pinsky DJ, Goonewardena SN.

Bioorg Med Chem. 2017 Aug 15;25(16):4487-4496. doi: 10.1016/j.bmc.2017.06.040. Epub 2017 Jun 30.

5.

Right atrial strain is predictive of clinical outcomes and invasive hemodynamic data in group 1 pulmonary arterial hypertension.

Bhave NM, Visovatti SH, Kulick B, Kolias TJ, McLaughlin VV.

Int J Cardiovasc Imaging. 2017 Jun;33(6):847-855. doi: 10.1007/s10554-017-1081-7. Epub 2017 Feb 6.

6.

Ectonucleotidase CD39-driven control of postinfarction myocardial repair and rupture.

Sutton NR, Hayasaki T, Hyman MC, Anyanwu AC, Liao H, Petrovic-Djergovic D, Badri L, Baek AE, Walker N, Fukase K, Kanthi Y, Visovatti SH, Horste EL, Ray JJ, Goonewardena SN, Pinsky DJ.

JCI Insight. 2017 Jan 12;2(1):e89504. doi: 10.1172/jci.insight.89504.

7.

Purinergic dysregulation in pulmonary hypertension.

Visovatti SH, Hyman MC, Goonewardena SN, Anyanwu AC, Kanthi Y, Robichaud P, Wang J, Petrovic-Djergovic D, Rattan R, Burant CF, Pinsky DJ.

Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H286-98. doi: 10.1152/ajpheart.00572.2015. Epub 2016 May 20.

8.

Flow-dependent expression of ectonucleotide tri(di)phosphohydrolase-1 and suppression of atherosclerosis.

Kanthi Y, Hyman MC, Liao H, Baek AE, Visovatti SH, Sutton NR, Goonewardena SN, Neral MK, Jo H, Pinsky DJ.

J Clin Invest. 2015 Aug 3;125(8):3027-36. doi: 10.1172/JCI79514. Epub 2015 Jun 29.

9.

Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study.

Visovatti SH, Distler O, Coghlan JG, Denton CP, Grünig E, Bonderman D, Müller-Ladner U, Pope JE, Vonk MC, Seibold JR, Torres-Martin JV, Doelberg M, Chadha-Boreham H, Rosenberg DM, McLaughlin VV, Khanna D.

Arthritis Res Ther. 2014 Dec 10;16(6):493. doi: 10.1186/s13075-014-0493-1.

10.

Increased CD39 nucleotidase activity on microparticles from patients with idiopathic pulmonary arterial hypertension.

Visovatti SH, Hyman MC, Bouis D, Neubig R, McLaughlin VV, Pinsky DJ.

PLoS One. 2012;7(7):e40829. doi: 10.1371/journal.pone.0040829. Epub 2012 Jul 11.

11.

Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain.

Petrovic-Djergovic D, Hyman MC, Ray JJ, Bouis D, Visovatti SH, Hayasaki T, Pinsky DJ.

J Immunol. 2012 Mar 1;188(5):2387-98. doi: 10.4049/jimmunol.1003671. Epub 2012 Jan 30.

12.

Paradoxical exacerbation of neuronal injury in reperfused stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted mice.

Ducruet AF, Sosunov SA, Visovatti SH, Petrovic-Djergovic D, Mack WJ, Connolly ES Jr, Pinsky DJ.

Neurol Res. 2011 Sep;33(7):717-25. doi: 10.1179/1743132810Y.0000000022.

13.

Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39.

Hyman MC, Petrovic-Djergovic D, Visovatti SH, Liao H, Yanamadala S, Bouïs D, Su EJ, Lawrence DA, Broekman MJ, Marcus AJ, Pinsky DJ.

J Clin Invest. 2009 May;119(5):1136-49. doi: 10.1172/JCI36433. Epub 2009 Apr 20.

14.

Suppression of nitrosative and oxidative stress to reduce cardiac allograft vasculopathy.

Hasegawa T, Iwanaga K, Hultquist DE, Liao H, Visovatti SH, Pinsky DJ.

Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1007-16. doi: 10.1152/ajpheart.00498.2008. Epub 2009 Jan 23.

15.

Ecto-5' nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy.

Hasegawa T, Bouïs D, Liao H, Visovatti SH, Pinsky DJ.

Circ Res. 2008 Dec 5;103(12):1410-21. doi: 10.1161/CIRCRESAHA.108.180059. Epub 2008 Nov 13.

16.

Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation.

Iwanaga K, Hasegawa T, Hultquist DE, Harada H, Yoshikawa Y, Yanamadala S, Liao H, Visovatti SH, Pinsky DJ.

Transplantation. 2007 Mar 27;83(6):747-53.

PMID:
17414708
17.

Heterotopic vascularized murine cardiac transplantation to study graft arteriopathy.

Hasegawa T, Visovatti SH, Hyman MC, Hayasaki T, Pinsky DJ.

Nat Protoc. 2007;2(3):471-80.

PMID:
17406609

Supplemental Content

Loading ...
Support Center